VYOME HOLDINGS, INC. Proceeds from Convertible Debt
VYOME HOLDINGS, INC. (HIND) reported Proceeds from Convertible Debt of $191.25 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2026-08-12
- VYOME HOLDINGS, INC. proceeds from convertible debt for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. proceeds from convertible debt for the quarter ending 2025-09-30 was $0.00.
- VYOME HOLDINGS, INC. proceeds from convertible debt for the quarter ending 2025-06-30 was $31.25K.
- VYOME HOLDINGS, INC. proceeds from convertible debt for the quarter ending 2025-03-31 was $160.00K.
- VYOME HOLDINGS, INC. proceeds from convertible debt for fiscal 2025 was $191.25K, a 71.33% decline from fiscal 2024.
- VYOME HOLDINGS, INC. proceeds from convertible debt for fiscal 2024 was $667.01K.
| Period end | Proceeds from Convertible Debt 1 month | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $31.25K derived: sum of 3 quarters · filed 2026-08-12 | $191.25K 10-K · filed 2026-03-18 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $31.25K derived: sum of 2 quarters · filed 2026-08-12 | $191.25K 10-Q · filed 2025-11-14 | $244.72K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $31.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $191.25K 10-Q · filed 2026-08-12 | $244.72K derived: sum of 3 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $160.00K 10-Q · filed 2026-05-12 | $213.47K derived: sum of 2 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $53.47K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $667.01K 10-K · filed 2026-03-18 | $653.00K 10-K · filed 2025-04-04 | |||
| 2024-10-31 | $800.00K 10-Q · filed 2025-08-14 | |||||
| 2024-09-30 | $613.54K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |